Iovance Biotherapeutics, Inc. (IOVA)
3.80
+0.91
(+31.49%)
USD |
NASDAQ |
Feb 24, 14:47
Iovance Biotherapeutics Market Cap : 1.508B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| KalVista Pharmaceuticals, Inc. | 797.12M |
| Lantheus Holdings, Inc. | 4.871B |
| Plus Therapeutics, Inc. | 39.63M |
| BioStem Technologies, Inc. | 97.24M |
| Protokinetix, Inc. | 3.069M |
Market Cap Related Metrics
| PS Ratio | 5.031 |
| Price to Book Value | 2.148 |
| Price | 3.80 |
| Earnings Yield | -31.63% |